{"name":"Novaremed Ltd.","slug":"novaremed-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NRD135S.E1","genericName":"NRD135S.E1","slug":"nrd135s-e1","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"NRD135S.E1","genericName":"NRD135S.E1","slug":"nrd135s-e1","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"GlobeNewswire","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxPMWdMTTRLVnZXYTgzYmtkQ0E2ZlJjQlA4S2s0amJ6OF9uM2VMcFdHdS1fdC1kTWg2alVmUjZlakcwNzJfenpfZmJnckxGZDZBT1Rub0NkTXByazEzREowUDd2NzN0QUhsZHAyVFBNZmxzMUx4MElxRmlpRklqSXlfcmFadjJ4SFhHOEdRUFh2blV5b0N6Y29YaS1QTGliV3NtMGxpYzhFRkozWHB0Uk15YzVpYVQzYXdaajZTMUZtUkZ2U3lzdTg2OUdyR3FlYm9SYXVUU2U4UlFtZ0s0YzlwTVl5VnZTVU9IRnMxYWVlSy1qMWpFa2hyQmFVS215ZS1XbmVTcnlJQXBOeUZ4NHdlNl82RzFEQ29MSkV5ZFEtdTVCU2lMaWF5Qw?oc=5","date":"2026-01-20","type":"trial","source":"GlobeNewswire","summary":"Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: - GlobeNewswire","headline":"Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxOY3UwTFY2ZGI5ZXJNUEJVZ3o0ZThCdTFOWm5uN0t4QU0xOUVrOU8ySndNOER3Y2VhVWlDZUJZcWxlc3FpQUFzNERwdTEzdjJyTllyalNuVmwzbEJzX1RUN3hpUDZWZkg0X3VxZmRfYlhhS1M5VDZrLWRxZEJBdFkzSlpFU2NJY2VnRTBGMl9kT2l1aURLbXhLbGtfQXFqWU0wWllEV2RkdkN0TndsbE1iVzZWX1lReXFYZkNTaVJuQUJlXzFQSi1HNjA0Ti1kaVNDcUE4QXBJZU1OUVV3Znk3aHZjdmxMR0pLYjJMUzhPNE51SlcwVGVZcm5DSFl1UGYwb0t2SmJlM0l6TC16TV8ydTNsZlRqanRhbUxsbk9maU82RVpiSmRzeg?oc=5","date":"2025-06-10","type":"trial","source":"GlobeNewswire","summary":"Diabetic Nephropathy Clinical Trial Analysis: Key Insights - GlobeNewswire","headline":"Diabetic Nephropathy Clinical Trial Analysis: Key Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPdGJBeU96MEg2dHVQQmFFcXEycnA4LUtpajM5U3hqSkdTdWo1X1lqVkF2QXNPeG9YOHU5VWlUWmFVdXZ5aGc4YTB1SWtoNmlDWDJqVEdMbWh0Y3hvR3ZLTlZEM3k1SXJjRjB2Mmt5OS1yUVI2NlB3Vk5WZFRKNlRiYW1QclFjUFFESklTb0tfQlgxNVAyclhSNWZEeGR1dUhla21sRGxlZTcyQXZwTWdRdDBUa0lMb0YzRDNFanQxM0tESTI4Tkt1ZUxsQXFFY29yclFjc3FTbEF2MkxjWUV3aHRydWl0Nks3VzNSeTl1YlFTeW5sYTAtRVZkcEI0dmU2dEpkamRxT212Smk4d2ppQ25pN3NTMjhHUV9pZkVxRERxLXdKMlBKei1yUGphZFJiWXdQSEN6ckpKRllpWlJoRWFJUUJWc19rUXVwamJHc1VwWmU0?oc=5","date":"2025-06-05","type":"pipeline","source":"Barchart.com","summary":"Diabetic Peripheral Neuropathy Market on Track for Major Expansion by 2034, According to DelveInsight | Grünenthal, Averitas Pharma, Daiichi Sankyo, Vertex Pharma, Helixmith, Lexicon Pharma, Glenmark ","headline":"Diabetic Peripheral Neuropathy Market on Track for Major Expansion by 2034, According to DelveInsight | Grünenthal, Aver","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9mcmJHVzZiZHZfYndGeWlMX0xaNUFVRFQ0MVJ1Y3dHa2hENmJpQUM0VEpsVWFubEdCcjNKOWFYR2dud252cmVtaHl2aFVzT0NMeUdBeEFIZEZnLUtrVWREcFU2QlJWUXJu?oc=5","date":"2022-06-07","type":"trial","source":"Wiley Online Library","summary":"NRD.E1, an innovative non‐opioid therapy for painful diabetic peripheral neuropathy—A randomized proof of concept study - Tiecke - 2022 - European Journal of Pain - Wiley Online Library","headline":"NRD.E1, an innovative non‐opioid therapy for painful diabetic peripheral neuropathy—A randomized proof of concept study ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxONXRRVFgtMVlSWS1yYmtiQXY3UTk1R1p4QmVGT1dTNWQ0NDJJZmNWQ3FPYmlfTThnZ3ROcjY2aXVnaTNmNFNZTlQ1ZDJnM25mVERESENCcl9sd0RtQ003b0ZyR3JadXdxbEZLUzNveFVubXJKVG90UUlDTFhhNlZlei1QZVFFdkZqbkNUWnNHV0NQOXc4bDhtUnZDdnRTc3pfWl9JdGYtTVc2N3BVbUVuUWxNbUViUkRfMGprNFRjUFRzRHdWTmhfY09FTDhiQnVSenNaT2pwTVNsU1l6VTF2WWdYaWZDRzJjQUZKYk1qVnVzbEFYNldXQjRUQjZfRGE1SEtNcXNvdGFxTkFGenE4VVF3Rk8?oc=5","date":"2021-12-21","type":"trial","source":"Via TT","summary":"Novaremed’s Non-opioid Lead Compound, NRD.E1, to be Tested in NIH HEAL Initiative Phase 2 Trial for the Treatment of Chronic Pain - Via TT","headline":"Novaremed’s Non-opioid Lead Compound, NRD.E1, to be Tested in NIH HEAL Initiative Phase 2 Trial for the Treatment of Chr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNQ1M0dkYtWHNuN1dsVGUxVmRMcHVadk1xdGh5X0hKaGVlNk1xb0hNVm9IcUc3TXJzWUhJaG1IT2lEUkxSNlFfa3p2Q0d6ZGc4S05DQU9SZGkzUDJvTG5fUmUtMHF0RE1PQXhQRWFNSXIzRGg1MDJxRUJwXzZiOGZYUlF4bVktQ0xSNEd5VmJEeURFMEk?oc=5","date":"2021-09-14","type":"deal","source":"startupticker.ch","summary":"Novaremed acquires Basel-based Metys Pharmaceuticals - startupticker.ch","headline":"Novaremed acquires Basel-based Metys Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9lTzlNYVlJOWh6TXdSUkE5VmRTa2VfeVc5RDZyS3haSTZSYTdveWR3MGp6Rl96ZDVlSjExaERKTXNta0NrSDlFLVVPdHdKUHFUeVllUUZaRzB1QnZnWkx5eDRIOEVobVAzWHc?oc=5","date":"2019-10-02","type":"pipeline","source":"Straits Research","summary":"Neuropathic Pain Market Size, Trends & Growth | 2033 - Straits Research","headline":"Neuropathic Pain Market Size, Trends & Growth | 2033","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}